: The AMEDEO Literature Guide

Home The Word Brain

My Amedeo

FAQ

Privacy

About

Hanzi Hunter — ultra-fast Hanzi study

All 1,152 characters from the aioLingua manual

Abstract • About • The 20 audio files

← aioLingua Chinese Online

← Chinese aioLingua PDF

Cervical Cancer, November 2025
Free Subscription

Abstracts
Retrieve all available abstracts of the following 327 articles:
HTML format

Single Articles

QI S, Chen Q, Liang J, Yang X, et al
Evaluating the quality and reliability of cervical cancer related videos on YouTube, Bilibili, and Tiktok: a cross-sectional analysis.
BMC Public Health. 2025;25:3682.
PubMed
Abstract available

MANTERYS K, Blazek M, Kowalczyk A
Type of treatment, operated organ and sexual functioning of patients with cervical cancer.
Support Care Cancer. 2025;33:1004.
PubMed
Abstract available

NAYAK P, Chopra S, Gupta Y, Saahil W, et al
Radiomics-based machine-learning approach to predict response at brachytherapy using pretreatment magnetic resonance imaging in locally advanced cervical cancer.
Brachytherapy. 2025 Oct 30:S1538-4721(25)00301.
PubMed
Abstract available

FOLEY OW, Strom D, Hinchcliff EM
Advances in Cervical Cancer.
Hematol Oncol Clin North Am. 2025;39:1121-1137.
PubMed
Abstract available

AL-MADHAGI S, Khashayar P, Volckaert L, Vanfleteren J, et al
Advancing cervical cancer screening: A novel in-house ELISA assay for the simultaneous detection of p16 and Ki-67.
J Immunol Methods. 2025 Oct 29:113998. doi: 10.1016/j.jim.2025.113998.
PubMed
Abstract available

CUI Y, Li Y, Na J, Lu J, et al
Integration of radiomics, habitat imaging, and deep learning for MRI-based prediction of parametrial invasion in cervical cancer: A dual-center study.
Magn Reson Imaging. 2025 Oct 29:110542. doi: 10.1016/j.mri.2025.110542.
PubMed
Abstract available

BAI H, Seo MG, Choi SY, Khaowroongrueng V, et al
Validated LC-MS/MS method for cisplatin quantification in plasma, whole blood, and cervical cancer tissue via diethyldithiocarbamate derivatization: Clinical application in cervical cancer.
J Pharm Biomed Anal. 2025;268:117180.
PubMed
Abstract available

GARIMA, Nambiar K, Mahajan P, Tanveer N, et al
Invasive stratified mucin-producing carcinoma of the cervix: A case report and review of the literature.
Indian J Pathol Microbiol. 2025;68:646-649.
PubMed
Abstract available

SAGNIC S, Tuncer SF, Tuncer HA, Dogan S, et al
Comparative Oncologic Outcomes in High-Risk Human Papillomavirus-Positive and -Negative Cervical Intraepithelial Neoplasia.
Med Sci Monit. 2025;31:e950452.
PubMed
Abstract available

OKYERE J, Aboagye RG, Ahinkorah BO, Essuman MA, et al
Assessing the socioeconomic inequalities in cervical cancer screening in sub-Saharan Africa: a decomposition analysis.
Int J Equity Health. 2025;24:297.
PubMed

LI JJ, Guan WY, Chu CZ, Chen YY, et al
[Potential value of HPV integration testing in a triage management for HPV-positive women].
Zhonghua Fu Chan Ke Za Zhi. 2025;60:788-797.
PubMed
Abstract available

[Expert consensus on diagnosis and treatment of neuroendocrine carcinoma of the cervix (2025)].
Zhonghua Fu Chan Ke Za Zhi. 2025;60:753-762.
PubMed

TAI CT, Chen YC, Hsieh YH, Lin CL, et al
Licoricidin Enhances Paclitaxel-induced Apoptosis Through Endoplasmic Reticulum Stress in Human Cervical Cancer Cells.
In Vivo. 2025;39:3195-3204.
PubMed
Abstract available

GAO Q, Wang Q, Hu Y, Xin F, et al
SIRT7 deficiency promoted cuproptosis-mediated mitochondrial dysfunction and inhibited malignant development of cervical cancer.
Arch Biochem Biophys. 2025 Oct 28:110651. doi: 10.1016/j.abb.2025.110651.
PubMed
Abstract available

LU Z, Ali R, Gall R, Velazquez-Miranda E, et al
Effectiveness of Human Papillomavirus Self-collection for Cervical Cancer Screening in Community Outreach Programs.
Arch Pathol Lab Med. 2025 Oct 31. doi: 10.5858/arpa.2025-0325.
PubMed
Abstract available

PANG G, Wang Z, Sun Z, Lv X, et al
Integrated Proteomics and Metabolomics Profiling Unveils Biomarkers and Immune Characteristics for Pelvic Lymph Node Metastasis in Cervical Cancer.
J Proteome Res. 2025 Oct 30. doi: 10.1021/acs.jproteome.5c00314.
PubMed
Abstract available

MILIJASEVIC D, Tamas T, Cankovic S, Ukropina S, et al
Inequalities in cervical cancer screening use: results of the Serbian National Health Survey.
Cent Eur J Public Health. 2025;33:155-162.
PubMed
Abstract available

WANG JN, Yu X, Gu LN, Liu DM, et al
Dosimetric and hematological toxicity analyses of bone marrow-sparing intensity-modulated radiation therapy for patients with cervical cancer treated with extended-field radiation therapy.
Precis Radiat Oncol. 2025;9:96-107.
PubMed
Abstract available

HUANG H, Du C, Liu G
China's actions for post-political commitment to global strategy to accelerate cervical cancer elimination.
Infect Agent Cancer. 2025;20:77.
PubMed
Abstract available

BERHANU W, Gobbo E, Herzig van Wees S, Hanson C, et al
Rumors and fears about the HPV vaccine: Perceptions of adolescent girls in government school in Addis Ababa.
Hum Vaccin Immunother. 2025;21:2578894.
PubMed
Abstract available

ISHIDERA Y, Iijima T, Aichi M, Ogawara Y, et al
Efficacy and Safety of Concurrent Chemoradiotherapy as First-Line Treatment for Stage IVB Cervical Cancer: A Single-Center Retrospective Observational Study.
J Obstet Gynaecol Res. 2025;51:e70119.
PubMed
Abstract available

HOLOVANOVA IA, Vovk OY, Mats TP, Filatova VL, et al
Medical and social substantiation of early detection and prevention of visual forms of cervical cancer.
Wiad Lek. 2025;78:1777-1788.
PubMed
Abstract available

SIMS TT, Yoshida-Court K, El Alam MB, Ramatlho P, et al
Cervical and Tumor-Associated Microbiomes in Botswana Women With and Without HIV With Carcinoma of the Cervix Before and After Definitive Chemoradiation.
JCO Glob Oncol. 2025;11:e2500036.
PubMed
Abstract available

MEDINA-RIVERO AS, Ratkovich-Gonzalez S, Ruiz-Briseno MDR, Rosas-Gonzalez VC, et al
The Role of Cervicovaginal Microbiota and Probiotics in Modulating HPV Persistence and Preventing Cervical Cancer.
ACS Infect Dis. 2025 Oct 29. doi: 10.1021/acsinfecdis.5c00385.
PubMed
Abstract available

AGUILAR JS, Holt HK, Beshers C, Baumann K, et al
Barriers and Facilitators to Colposcopy Follow-up After Abnormal Cervical Cancer Screening: Qualitative Insights From an Urban Health Care Setting.
J Midwifery Womens Health. 2025 Oct 29. doi: 10.1111/jmwh.70041.
PubMed
Abstract available

ZHAO R, Kulasingam S, Alarid-Escudero F, Minihan AK, et al
Public-health impact of increasing human papillomavirus vaccination and cervical cancer screening.
J Natl Cancer Inst. 2025 Oct 24:djaf311. doi: 10.1093.
PubMed
Abstract available

JEYACHANDRAN K, Pakirithodiyil MA, Aruldoss K, Lal M, et al
Development and clinical validation of a clinically translatable non-chip-on-tip transvaginal imaging system (GynoSight v2.0) for early detection of premalignant cervical lesions.
J Biomed Opt. 2025;30:106002.
PubMed
Abstract available

XIE X, Guan H, Li M, Gao W, et al
Advances in exosomal non-coding RNAs in cervical cancer (Review).
Mol Clin Oncol. 2025;23:104.
PubMed
Abstract available

HUANG X, Lu S, Li X, Wu J, et al
Multi-omics profiling reveals the role of 4-ethylbenzoic acid in promoting proliferation and invasion of cervical cancer.
Front Med (Lausanne). 2025;12:1591531.
PubMed
Abstract available

WANG H, Liu J, A X, Wang J, et al
CMTM4 overexpression inhibited tumor growth through regulating the function of myeloid-derived suppressor cells in the cervical cancer microenvironment.
Transl Cancer Res. 2025;14:5490-5503.
PubMed
Abstract available

MONTERO-MACIAS R, Adam M, Rouzier R, Bonneau C, et al
HPV vaccination efficacy in primary and tertiary prevention of vulvar and vaginal HPV-related high grade dysplasia and cancers: A systematic review.
Hum Vaccin Immunother. 2025;21:2567704.
PubMed
Abstract available

PRUSKI D, Millert-Kalinska S, Jach R, Zurawski J, et al
Impact of Vaccinating Adult Women Who Are HPV-Positive or with Confirmed Cervical SIL with the 9-Valent Vaccine-A Systematic Review.
Viruses. 2025;17:1377.
PubMed
Abstract available

TAMAI K, Kinjo S, Taguchi A, Nagasaka K, et al
Elucidating Alterations in Viral and Human Gene Expression Due to Human Papillomavirus Integration by Using Multimodal RNA Sequencing.
Viruses. 2025;17:1344.
PubMed
Abstract available

BERBER L, Foy O, Cantu J Jr, Ehrenpreis ED, et al
Patients with Newly Diagnosed Cervical Cancer Should Be Screened for Anal Human Papillomavirus (HPV) and Anal Dysplasia: Results of Cost and Quality Analysis.
Pathogens. 2025;14:1007.
PubMed
Abstract available

LEE WH, Kim SC, Park S, Park JW, et al
EZH2-Mediated PTEN Silencing Promotes AKT-Dependent Afatinib Resistance in Radiation-Resistant Cervical Cancer Cells.
J Clin Med. 2025;14:7329.
PubMed
Abstract available

HURJUI RM, Hurjui IA, Butureanu TA, Popovici D, et al
HPV-Independent Cervical Cancer-A New Challenge of Modern Oncology.
Int J Mol Sci. 2025;26:10051.
PubMed
Abstract available

MWANGI JH, Mbeje PN, Mtshali GN
Challenges and Opportunities of Male Partner Involvement in Cervical Cancer Prevention and Control in Central Kenya: A Qualitative Analysis.
Int J Environ Res Public Health. 2025;22:1575.
PubMed
Abstract available

RACHADECH N, Phookiaw S, Charoenkwan K
Effect of Conization Prior to Radical Hysterectomy on Overall and Progression-Free Survival in Early-Stage Cervical Cancer: A Propensity Score-Matched Analysis.
Cancers (Basel). 2025;17:3360.
PubMed
Abstract available

PILLAY J, Gates A, Guitard S, Zakher B, et al
Screening for the prevention and early detection of cervical cancer: systematic reviews to inform an update to recommendations by the Canadian Task Force on Preventive Health Care.
Syst Rev. 2025;14:206.
PubMed
Abstract available

MAEMOTO H, Sakihama S, Karube K, Kudaka W, et al
Genomic Features of Cervical Cancer in Okinawa, Japan: Preliminary Findings From 23 Patients.
Cancer Genomics Proteomics. 2025;22:1069-1080.
PubMed
Abstract available

LASIC M, Ostrbenk A, Smrkolj S, Bohinc KB, et al
Prevalence of High-Risk Human Papillomaviruses (HPV) in Slovenian Women Attending Organized National Cervical Cancer Screening 14 Years After Implementation of the National HPV Vaccination Program.
Vaccines (Basel). 2025;13:1050.
PubMed
Abstract available

MELO CPS, Melo AB, Queiroz FR, Costa AP, et al
Differentially Expressed Genes Identify FIGO Stage II Cervical Cancer Patients with a Higher Risk of Relapse in a Small Cohort.
J Pers Med. 2025;15:497.
PubMed
Abstract available

PEREZ S
Cervical Cancer Elimination Requires Systems, Trust, and Action.
Curr Oncol. 2025;32:565.
PubMed
Abstract available

WANG Y, Zhou X, Xi Y, Lou H, et al
PET/CT Imaging Characteristics of Gastric-Type Endocervical Adenocarcinoma: Findings from a Small Exploratory Series.
Curr Oncol. 2025;32:530.
PubMed
Abstract available

HALAS-WISNIEWSKA M, Zawadka P, Arendt W, Izdebska M, et al
From Adhesion to Invasion: Integrins, Focal Adhesion Signaling, and Actin Binding Proteins in Cervical Cancer Progression-A Scoping Review.
Cells. 2025;14:1640.
PubMed
Abstract available

KASHYAP VK, Kenchappa DB, Singh AK, Singh B, et al
Alcohol Consumption and Cervical Carcinogenesis: Time to Draw Conclusions.
Cells. 2025;14:1639.
PubMed
Abstract available

SRIPAN P, Aurpibul L, Srithanaviboonchai K, Tangmunkongvorakul A, et al
Factors Associated with Suboptimal Screening for Cervical Cancer among Ethnic Women in Thailand-Myanmar Border Area.
Asian Pac J Cancer Prev. 2025;26:3727-3736.
PubMed
Abstract available

SUKHABOT K, Jaengpromma P, Praphasawat R, Pimalram P, et al
Effective Anti-Cancer Activity of Red Rice Bran Extract on Cervical Cancer and Breast Cancer Cells.
Asian Pac J Cancer Prev. 2025;26:3719-3725.
PubMed
Abstract available

DILLARD A, Marshall SM, Teneza JN, Kekauoha BP, et al
The Adoption of Cancer Screening and Prevention in Hawaiian Homestead Communities.
Asian Pac J Cancer Prev. 2025;26:3691-3697.
PubMed
Abstract available

ABREFAH E, Agyei-Baffour P, Owusu AB, Commeh ME, et al
Human Papillomavirus (HPV) Vaccination and Cervical Cancer Prevention: Ghanaian Adolescent Students' Perspectives Through Focus Group Discussion.
Asian Pac J Cancer Prev. 2025;26:3679-3689.
PubMed
Abstract available

SHOJAPOUR M, Mosayebi G, Fathi Y, Soleimani H, et al
In vitro Evaluation of the Combined Effects of a Static Magnetic Field and Curcumin on MCF7 and HeLa Cell Lines.
Asian Pac J Cancer Prev. 2025;26:3653-3662.
PubMed
Abstract available

GRACA ADV, Soares LC, Brollo JLA
Barriers to HPV Vaccination in Brazil: A Systematic Review.
Asian Pac J Cancer Prev. 2025;26:3549-3560.
PubMed
Abstract available

SAIDA T, Saitoh T, Shikama A, Hayashi M, et al
Cervical cancer in the modern era: cutting-edge strategies for diagnosis and treatment.
Jpn J Radiol. 2025 Oct 28. doi: 10.1007/s11604-025-01897.
PubMed
Abstract available

LU X, Song P, Chen Q
lncRNA PAX8-AS1 suppresses cervical cancer development by regulating miR-675-3p/DCN axis.
Int J Biol Markers. 2025 Oct 28:3936155251386471. doi: 10.1177/03936155251386471
PubMed
Abstract available

HAGIU DP, Saquet M, Partouche H, Gilberg S, et al
Impact of a shared medical decision-making aid on patient decisional conflict regarding human papillomavirus vaccination: a mixed-methods study.
Fam Pract. 2025;42:cmaf077.
PubMed
Abstract available

GODOY LR, El-Zein M, Cools P, Padalko E, et al
E6/E7 Similarity to Human Papillomavirus Prototypes and Performance of HPV Testing by Cobas 4800 HPV Test and Anyplex II HPV HR.
J Med Virol. 2025;97:e70668.
PubMed
Abstract available

YANG Y, Sun C, Wang H
Prediction of Cervical Cancer Progression Leveraging HPV16 Integration-Related Genes.
Int J Womens Health. 2025;17:3745-3760.
PubMed
Abstract available

ADAM J, Sougou NM
Cervical cancer screening and its associated factors among women of reproductive age in senegal: evidence from 2023 continuous demographic and health survey in Senegal.
BMC Public Health. 2025;25:3617.
PubMed
Abstract available

YOSHIDA K, Morita H, Nakai M, Kawamura Y, et al
Development and validation of predictive model for emesis in cervical cancer patients receiving concurrent chemoradiotherapy based on multi-institutional retrospective study.
Sci Rep. 2025;15:37508.
PubMed
Abstract available

XIA M, Yuan L, Chen L, Wen W, et al
CREB5 promotes nodal metastasis of cervical cancer by regulation of APLN-induced lymphangiogenesis.
Cell Death Discov. 2025;11:488.
PubMed
Abstract available

ALFARO K, Lopez L, Soler M, Conzuelo Rodriguez G, et al
Long-term outcomes after cervical cancer screening in El Salvador: primary human papillomavirus screen-and-treat compared with cytology.
BMJ Glob Health. 2025;10:e017983.
PubMed
Abstract available

YOSHIMOTO D, Iuchi H, Taguchi A, Sone K, et al
Downregulation of HLA Class I Expression Through HLA-A DNA Methylation Is Associated with Reduced CD8+ T Cell Infiltration in Cervical Cancer.
Cancer Immunol Res. 2025 Oct 27. doi: 10.1158/2326-6066.CIR-25-0594.
PubMed
Abstract available

DI GIUSEPPE J, Bernardi M, Cicoli C, Terenzi T, et al
Cervical cancer prevention and colposcopy in pregnancy: a nationwide survey of Italian colposcopists from the Italian Society of Colposcopy and Cervico-Vaginal Pathology.
Eur J Cancer Prev. 2025 Oct 1. doi: 10.1097/CEJ.0000000000000991.
PubMed
Abstract available

GUETTERMAN TC, Vinson A, Stack M, Alves ML, et al
Rural women choose self-sampling over a pelvic exam for cervical cancer screening: a mixed-method study.
Cancer Causes Control. 2025 Oct 27. doi: 10.1007/s10552-025-02081.
PubMed
Abstract available

DONG M, Zhang C, Zhang X, Su Y, et al
Integrated WGCNA retrieval of T-cell exhaustion genes related to radiosensitivity in locally advanced cervical cancer and prediction of immunotherapy efficacy.
Discov Oncol. 2025;16:1971.
PubMed
Abstract available

KOLINA AD, Danilova NV, Andreeva YY
[Predictive immunotherapeutic markers of adenocarcinomas and adenosquamous carcinoma of the cervix].
Arkh Patol. 2025;87:74-79.
PubMed
Abstract available

SEDAGHAT S, Nikbakht Brujeni G, Shamsian SAA, Sohrabi Haghdoost N, et al
Association between HLA-DRB1.2 Genotypic Diversity and Cervical Cancer in Women Infected with the Human Papillomavirus.
Iran J Allergy Asthma Immunol. 2025;24:643-652.
PubMed
Abstract available

BURAYU ET, Degefa BD, Zegeye ZB, Bekele GG, et al
Incidence and predictors of mortality among cervical cancer patients in Sub-Saharan Africa: a systematic review and meta-analysis.
AJOG Glob Rep. 2025;5:100570.
PubMed
Abstract available

SHEN H, Jiang Y, Zhang L, Zheng Q, et al
Predicting preoperative lymph node status in patients with cervical cancer: development of interpretable machine learning model and support for the biological plausibility.
Front Immunol. 2025;16:1654332.
PubMed
Abstract available

XU Y, Gong X, He H, Deng X, et al
Salvage sequential integrated boost radiotherapy followed by sintilimab-bevacizumab in cervical small-cell carcinoma with >10 brain metastases: A 3-year survivor case report.
Front Immunol. 2025;16:1590848.
PubMed
Abstract available

ZHU Q, Yu S
The role of cGAS-STING signaling in HPV infection and HPV-related cancers.
Front Immunol. 2025;16:1709613.
PubMed
Abstract available

CUI Y, Liu Z, Zhang L, Men K, et al
Construction of a novel cuproptosis-related gene signature for predicting microenvironment, prognosis and therapeutic response in cervical cancer.
Front Oncol. 2025;15:1532772.
PubMed
Abstract available

ALSHDAIFAT EH, Sindiani AM, Alhatamleh S, Abu Mhanna HY, et al
Enhancing cervical cancer diagnosis with ensemble learning and shark optimization algorithm: comparative study of CT and MRI in cervical cancer diagnosis.
Front Oncol. 2025;15:1608386.
PubMed
Abstract available

WU A, Wang S, Wang D, Xue P, et al
The Infection Status and Distribution of hrHPV in Cervical Lesions Among Overweight Women Referred for Colposcopy: A Cross-Sectional Study.
Cancer Control. 2025;32:10732748251390954.
PubMed
Abstract available

ADEKUNLE TE, Adekunle TB, Thomas S
Reconstructing trust in preventive care: Black women's perspectives on equity-centered, cervical cancer interventions.
Ethn Health. 2025 Oct 26:1-18. doi: 10.1080/13557858.2025.2577130.
PubMed
Abstract available

FENG S, Wang H, Duan X, Chen S, et al
Revolutionizing cervical cancer care: the synergistic effects of hyperthermia and machine learning.
Int J Hyperthermia. 2025;42:2564343.
PubMed
Abstract available

LIU L, Ma L, Wang Y, Chen Y, et al
Effect of Baofukang suppository on the relative indexes of epithelial mesenchymal transformation of tumor cells and prognosis in patients with cervical cancer.
Pak J Pharm Sci. 2025;38:2146-2153.
PubMed
Abstract available

HUANG X, Zhuang Y, Wang R, Qu J, et al
Colonization by Porphyromonas gingivalis in cervical squamous cell carcinomas promotes metastasis through FimA/CD151/ITGB1 signaling.
J Transl Med. 2025;23:1166.
PubMed
Abstract available

COLNEY Z, Laldinmawii G, Singson S, Royte V, et al
Unveiling the burden of human papillomavirus infection and risk factors among Indigenous women in Mizoram, Northeast India.
BMC Infect Dis. 2025;25:1406.
PubMed
Abstract available

WANG X, Wu Y, Huang J, Zong D, et al
Bispecific antibodies (PD-1/CTLA-4) vs. PD-1 inhibitors with platinum-based chemotherapy+/-bevacizumab as first-line therapy for persistent, recurrent, or metastatic cervical cancer: a retrospective matched cohort study.
Cancer Immunol Immunother. 2025;74:347.
PubMed
Abstract available

AMETA GK, Ramkumar MS, Jenifa G, Sivaramkrishnan M, et al
Cervical cancer prediction using deformable kernel darknet-53 and depth wise separable convolutional neural networks.
Sci Rep. 2025;15:37236.
PubMed
Abstract available

RETRACTION: Protective Effect of Tretinoin on Cervical Cancer Growth and Proliferation Through Downregulation of pFAK2 Expression.
Environ Toxicol. 2025 Oct 24. doi: 10.1002/tox.24587.
PubMed
Abstract available

JIANG N, Ping X, Meng Q, Liu Y, et al
Development, validation, and visualization of a novel nomogram for predicting clinical outcomes of radiotherapy combined with chemotherapy in locally advanced cervical cancer.
Front Oncol. 2025;15:1668971.
PubMed
Abstract available

OZDEMIR BG, Almali DA
Letter: Comment on "Long Noncoding RNA DLX6-AS1 Promotes the Progression in Cervical Cancer by Targeting miR-16-5p/ARPP19 Axis".
Cancer Biother Radiopharm. 2025 Oct 24. doi: 10.1177/10849785251392781.
PubMed

RIOS-MONTEZA P, Solis-Ponce L, Espetia S, Eklund C, et al
Nationwide implementation and evaluation of an external quality assessment program for HPV screening in Peru.
Int J Infect Dis. 2025;160:108067.
PubMed
Abstract available

PANDEY M, Shanmugham D, Palani R, Nagarajan P, et al
Pelvic organ prolapse and cervical adenocarcinoma in a postmenopausal woman: A case report.
Trop Doct. 2025;55:344-346.
PubMed
Abstract available

TAL BLIMAN Y, Rafaeli Yehudai T, Shiber Y, Mor M, et al
Spontaneous pyometra in postmenopausal women and gynecologic cancer-a preliminary study based on experience of a tertiary medical center.
Menopause. 2025;32:1022-1027.
PubMed
Abstract available

ORJI AF, Gimm G, Parekh T, Turpin R, et al
Disparities in human papillomavirus vaccination uptake across the intersection of disability and sexual orientation.
Cancer Causes Control. 2025;36:1385-1397.
PubMed
Abstract available

ABAY H, Cakmak B, Alagoz FM, Uzunlar O, et al
The relationship between human papillomavirus (HPV) knowledge and HPV vaccine acceptance among women and affecting factors in Turkiye.
Cancer Causes Control. 2025;36:1249-1262.
PubMed
Abstract available

ANWER MA, Sinha R, Bharti S, Surabhi, et al
Clinicopathological association of programmed death-ligand 1 ( PD-L1 ) expression in uterine cervical carcinomas: A cross-sectional observational study.
Indian J Pathol Microbiol. 2025;68:472-477.
PubMed
Abstract available

SCHAAFSMA M, Schuurman TN, van Maurik IS, Bekkers RLM, et al
Optimal follow-up strategy using high-risk HPV testing and cytology after conservative treatment for cervical adenocarcinoma in situ.
Am J Obstet Gynecol. 2025 Jun 5:S0002-9378(25)00367.
PubMed
Abstract available

ERIKSEN DO, Lycke KD, Kahlert J, Ostenfeld EB, et al
Active surveillance of cervical intraepithelial neoplasia grade 2 is not associated with an increased risk of non-cervical anogenital HPV-related cancer and precancer a population-based cohort study.
Am J Obstet Gynecol. 2025 Jun 3:S0002-9378(25)00366.
PubMed
Abstract available

YONG X, Xu X, Zhang X, Song R, et al
The m6 A modification of CDKN2 A inhibites ferroptosis and affects the resistance of cervical squamous cell carcinoma to cisplatin.
Naunyn Schmiedebergs Arch Pharmacol. 2025;398:15747-15761.
PubMed
Abstract available

GUI B, Russo L, Bharwani N, Cunha TM, et al
European Society of Urogenital Radiology (ESUR) guidelines on MR imaging prior to fertility-sparing treatments in patients with cervical, endometrial, and ovarian cancers.
Eur Radiol. 2025;35:7244-7259.
PubMed
Abstract available

CHEUNG MA, McKeown CD, McCarthy CM
Outcomes and Management of Atypical Squamous Cells-Cannot Exclude High-Grade Squamous Intraepithelial Lesion in a Primary Human Papillomavirus Screening System.
Arch Pathol Lab Med. 2025;149:1022-1026.
PubMed
Abstract available

MOUCHERAUD C, Ochieng E, Golub G, Navario P, et al
Kenyan men and cervical cancer prevention: Insights from a national survey.
Cancer Epidemiol Biomarkers Prev. 2025 Nov 7. doi: 10.1158/1055-9965.EPI-25-0987
PubMed
Abstract available

KULKARNI P, Khare S, Bramhachari S, Das S, et al
Collagen-Embedded Three-Dimensional Spheroid Model Based on Breast and Cervical Cancer for Drug Screening Application.
Cureus. 2025;17:e93920.
PubMed
Abstract available

XIAO N, Yuan C, Zhao T, Xu T, et al
Comparative impact of supine vs prone positioning on dose distribution, acute toxicity, and setup error in postoperative radiotherapy for cervical cancer: a multidimensional propensity-matched cohort study.
Front Oncol. 2025;15:1637443.
PubMed
Abstract available

CHEN L, Chen W, Lin Y, Li X, et al
Serum immune parameters as predictors for treatment outcomes in cervical cancer treated with concurrent chemo-radiotherapy.
Chin Med J (Engl). 2025 Nov 7. doi: 10.1097/CM9.0000000000003553.
PubMed
Abstract available

TIAN X, Lin R, Bao J, Pan Y, et al
Integrated single-cell, spatial, and bulk transcriptomics reveal a chromatin regulator-TME prognostic framework guiding precision therapy in cervical cancer.
J Transl Med. 2025;23:1235.
PubMed
Abstract available

ABU-ELENIN MM, Shahin MA, Abdeldaim DE
Preventive insights and practices of female health professionals regarding cervical cell dysplasia: a cross-sectional study in Egypt.
BMC Public Health. 2025;25:3809.
PubMed
Abstract available

SHIMADA Y, Ono H, Takeda K, Shimizu A, et al
Myiasis in a Skull Metastatic Nest of Cervical Cancer.
J Dermatol. 2025;52:1718-1721.
PubMed
Abstract available

PU C, Xing B, Wang S, Liu Z, et al
Advancements in single-cell sequencing for cervical cancer research.
Mol Cell Biochem. 2025 Nov 6. doi: 10.1007/s11010-025-05407.
PubMed
Abstract available

LU L, Wang F, Wang T, Xing Z, et al
Hypoxia drives cervical cancer progression via OCT4/ORAI3-dependent glycolysis and Ca(2+) signaling.
Cell Mol Life Sci. 2025;82:390.
PubMed
Abstract available

KANTZOU I, Georgakopoulos I, Markou I, Vorgias G, et al
Three Dimensional Conformal versus Volumetric Arc Therapy in Gynecological Cancer: A Retrospective Study Evaluating Therapeutic Effect and Toxicity.
Chirurgia (Bucur). 2025;120:538-545.
PubMed
Abstract available

MA J, Ma F, Chen T, Lu X, et al
Precision Diagnosis and Individualized Therapy of Non-Gestational Choriocarcinoma Invading the Corpus Uteri and Cervix: A Case Report and Literature Review.
Cancer Rep (Hoboken). 2025;8:e70393.
PubMed
Abstract available

TRUJANO-CAMACHO S, Contreras-Romero C, Garcia-Castillo V, Sanchez-Marin D, et al
Long noncoding RNAs involved in therapeutic response: implications for cervical cancer drug resistance.
Front Oncol. 2025;15:1644104.
PubMed
Abstract available

LIU W, Jing L, Huang X, Huang H, et al
Cost-effectiveness of cervical cancer screening and HPV vaccination: a Markov model from the healthcare payer perspective.
Front Public Health. 2025;13:1508623.
PubMed
Abstract available

AKBARI F, Vejdani R, Yaghoubi-Kondelaji S, Zarghami F, et al
Fertility Preservation in Extramedullary Plasmacytoma of the Uterine Cervix: Global Literature Synthesis and First Case From Iran.
J Obstet Gynaecol Res. 2025;51:e70130.
PubMed
Abstract available

YOO D, Kim H, Park S, Choi H, et al
Validating clinical feasibility of MRCAT and deep learning-based synthetic CT images for cervical cancer patient.
J Appl Clin Med Phys. 2025;26:e70332.
PubMed
Abstract available

DESCAMPS P, Dixon S, Bosch Jose FX, Kyrgiou M, et al
Turning the Tide: Recommendations to Increase Cervical Cancer Screening Among Women Who Are Underscreened.
Obstet Gynecol Surv. 2025;80:702-704.
PubMed
Abstract available

AL-HEJRI AM, Al-Tam RM, Sable AH, Almuhaya B, et al
A hybrid vision transformer with ensemble CNN framework for cervical cancer diagnosis.
BMC Med Inform Decis Mak. 2025;25:411.
PubMed
Abstract available

LI C, Luo P, Tang L, Yang Y, et al
Digoxin targets BHLHE40 to inhibit epithelial-mesenchymal transition in cervical cancer cells via downregulation of ANGPTL3.
J Nat Med. 2025 Nov 5. doi: 10.1007/s11418-025-01947.
PubMed
Abstract available

BISKUP E, Andreou I, Poulsen TS, Lopacinska-Jorgensen J, et al
Comparative Performance of Methylation Array and Bisulfite Sequencing in Ovarian Tissue Samples and Cervical Swabs.
Cancer Control. 2025;32:10732748251386499.
PubMed
Abstract available

MO D, Cao H, Lai S, Luo J, et al
Spatial transcriptomic landscape and cellular neighborhood heterogeneity in cervical cancer: integrative single-cell and spatial RNA sequencing analysis.
Discov Oncol. 2025;16:2040.
PubMed
Abstract available

XU J, Wang M, Jia Y, Chen Y, et al
Study on Differential Metabolites Between Human Papillomavirus Infection and Cervical Cancer Based on Non-Targeted Metabolomics.
Int J Womens Health. 2025;17:3995-4009.
PubMed
Abstract available

SILAS GD, Uggh IHP, Njau B, Majaliwa E, et al
Female sex workers and cervical cancer screening in Kilimanjaro region: Uptake and Behavioural Determinants in Health Belief Model Perspectives: A community-based cross-sectional study.
BMJ Public Health. 2025;3:e002543.
PubMed
Abstract available

LOVING HS
Practical Considerations for Cervical Cancer Screening.
J Appl Lab Med. 2025;10:1771-1772.
PubMed

OSTENFELD EB, Bjornholt SM, Jensen PT
Lymph node removal and long-term lymphedema in cervical cancer. (Reply to Letter-to-the-Editor).
Am J Obstet Gynecol. 2025 Nov 2:S0002-9378(25)00819.
PubMed

LI Q
Long-term lymphedema and quality of life following lymph node staging in early cervical cancer (Letter-to-the-Editor).
Am J Obstet Gynecol. 2025 Nov 2:S0002-9378(25)00818.
PubMed

DOLORES E, Kaire I, Reeli H, Piret V, et al
Prevalence of Human Papillomavirus Subtypes and Related Cytology in Estonian Cervical Cancer Screening Population in 2021.
Cancer Control. 2025;32:10732748251376787.
PubMed
Abstract available

WU Y, Wang A
A Review on the Applications of Artificial Intelligence for Diagnosing and Treating Cervical Cancer.
Int J Womens Health. 2025;17:3955-3970.
PubMed
Abstract available

AL-OSEELY S, Abdul Manaf R, Ismail S
Effectiveness of educational intervention on cervical cancer screening knowledge, attitude, and practice among Yemeni immigrant women in Klang Valley, Malaysia: a randomized controlled trial.
Trials. 2025;26:466.
PubMed
Abstract available

GUAN CY, Li J, Li SX, Li HL, et al
[Application value and missed diagnosis analysis of p16/Ki-67 immunocytochemical double staining technique in cervical lesion screening].
Zhonghua Bing Li Xue Za Zhi. 2025;54:1208-1211.
PubMed

CASTLE PE, Befano B, Hyer M, Cheung LC, et al
Impact of repeatedly screening negative on cervical cancer risk.
J Natl Cancer Inst. 2025 Nov 3:djaf317. doi: 10.1093.
PubMed
Abstract available

MANTOANI PTS, Melo GA, Vieira JH, Correa Magalhaes T, et al
Hematological parameters and colposcopic lesion area in precursor lesions of cervical cancer.
Ceska Gynekol. 2025;90:309-314.
PubMed
Abstract available

DENG JX, Zhang LY, Ouyang ZQ, Guo T, et al
TM4SF1 as a Prognostic Biomarker and Therapeutic Target in Cervical Cancer.
Curr Med Sci. 2025 Nov 3. doi: 10.1007/s11596-025-00123.
PubMed
Abstract available

OBEAGU EI
Integrating neutrophil-to-lymphocyte ratio into cervical cancer management: implications for prognostic assessment and therapeutic strategies - a narrative review.
Ann Med Surg (Lond). 2025;87:7362-7368.
PubMed
Abstract available

OBEAGU EI
From inflammation to invasion: neutrophils in cervical cancer pathogenesis.
Ann Med Surg (Lond). 2025;87:7112-7127.
PubMed
Abstract available

TSUI WL, Deng GH, Hsieh TC, Li PC, et al
Comparison of survival between open and minimally invasive radical hysterectomies for stage IB1 cervical cancer (
Tzu Chi Med J. 2025;37:430-436.
PubMed
Abstract available

ZHANG Z, Luo X, Zhao H
Commentary: A quantitative analysis of artificial intelligence research in cervical cancer: a bibliometric approach utilizing CiteSpace and VOSviewer.
Front Oncol. 2025;15:1666369.
PubMed

AKONDE M, Anyinka J, Abah GA, Gupta RD, et al
Factors associated with clinical breast examination and cervical cancer screening uptake in Ghanaian women, Evidence from the 2022 Ghana Demographic and Health Survey.
Afr Health Sci. 2025;25:123-135.
PubMed
Abstract available

KING BG, Bharwani N, Wilson W, Cook GJR, et al
Diagnostic performance of quantitative measures from [(18)F]FDG PET/CT, [(18)F]FEC PET/CT, and DW-MRI in the detection of lymph node metastases in endometrial and cervical cancer: data from the MAPPING study.
Eur J Nucl Med Mol Imaging. 2025 Nov 3. doi: 10.1007/s00259-025-07587.
PubMed
Abstract available

DU H, Dai W, Wu D, Liu Y, et al
Expanding access to cervical cancer screening: the performance of self-sampled urine HPV testing.
Int J Infect Dis. 2025 Oct 30:108175. doi: 10.1016/j.ijid.2025.108175.
PubMed
Abstract available

CHUNG PYJ, Baraquin A, Jacquot K, Tkachenka Y, et al
Reproducibility of HPV Testing With Two Versions of the Papilloplex High-Risk HPV Assay.
J Med Virol. 2025;97:e70680.
PubMed
Abstract available

BANET N, Talia KL
Cytology and histology of endocervical glandular lesions: a review with emphasis on recent developments.
Pathology. 2025;57:817-830.
PubMed
Abstract available

ZHU H, Zhang Z, Ye J, Yang H, et al
Evaluation of the Antitumor Efficacy of Human Papillomavirus Type 16 E7-Affitoxin in C57BL/6JNifdc Mice Bearing TC-1 Tumors.
Mol Pharm. 2025;22:6989-6998.
PubMed
Abstract available

SHAH V, Shah D, DeStefano V, Bonetti M, et al
Occupational-Related Exposure to Benzene and Risk of Cervical, Ovarian, and Endometrial Cancers: Systematic Review and Meta-analysis.
Cancer Epidemiol Biomarkers Prev. 2025;34:1877-1887.
PubMed
Abstract available

LI J, Zheng C, Zhang L, Hong C, et al
In Situ Formed Nanocomposite Hydrogel Improve Local Delivery of Antiangiogenic Agents and Immune Checkpoint Inhibitor for Cervical Carcinoma Therapy.
Adv Healthc Mater. 2025;14:e2502085.
PubMed
Abstract available

YANG L, Babalola C, Klausner JD
A Narrative Review of Urine-Based Human Papillomavirus Screening: Performance, Challenges, and Opportunities to Expand Access in the United States.
Sex Transm Dis. 2025;52:769-774.
PubMed
Abstract available

MACHADO P, Vu T, Rosenblum N, Shafer A, et al
Initial Evaluation of Lymphosonography to Identify Sentinel Lymph Nodes in Cervical and Vulvar Cancer Patients.
J Clin Ultrasound. 2025;53:2159-2164.
PubMed
Abstract available

BASHARI N, Davari M, Akbarisari A, Khorasani E, et al
Cost-effectiveness analysis of different types of human papillomavirus vaccination to prevent cervical cancer in Iran.
BMC Public Health. 2025;25:3927.
PubMed

WANG CR, Wang DM, Yin GY, Wang YH, et al
Isolation and characterization of canine adenovirus type 2 (CAV-HN45) and its selective infection of human cervical cancer cells with preliminary oncolytic potential.
Front Vet Sci. 2025;12:1692395.
PubMed
Abstract available

MTUYA CC, Cadstedt J, Mattsson J, Manhica HA, et al
"Cervical Cancer-A Silent Disease in the Community"-A Qualitative Study on Awareness of Cervical Cancer in Tanzania.
SAGE Open Nurs. 2025;11:23779608251393079.
PubMed
Abstract available

DEWAN P, Somani V, Mon MM
When Metastatic Cervical Cancer Presents as Miliary Lung Nodules.
Eur J Case Rep Intern Med. 2025;12:005806.
PubMed
Abstract available

ONGARO S, Desreux J, Tremblay-Lemoine PL, Schoenen S, et al
[Cervical cancer screening : implementation of the hr-HPV test].
Rev Med Liege. 2025;80:729-734.
PubMed
Abstract available

YIN M, Dai J, Sun R, Wang Y, et al
Diagnostic performance of PAX1 methylation as a biomarker for cervical lesions: a clinical study and meta-analysis.
Ann Med. 2025;57:2583319.
PubMed
Abstract available

LINXI J, Shiling L, Hongli Z
Comment on "Metabolic Effects of Healing Touch During Cervical Cancer Treatment: An Exploratory Analysis".
Integr Cancer Ther. 2025;24:15347354251397374.
PubMed

GOROSTIDI M, Angeles M, Gil-Ibanez B, Lekuona A, et al
Surgical Staging in Locally Advanced Cervical Cancer: Precision, Risks, and the 'Helmet' Analogy.
Cancers (Basel). 2025;17:3487.
PubMed
Abstract available

CHEN X, Yang Y, Li Y, Zhou J, et al
Study on the Trend of Cervical Cancer Inpatient Costs and Its Influencing Factors in Economically Underdeveloped Areas of China, 2019-2023: An Analysis in Gansu Province.
Healthcare (Basel). 2025;13:2663.
PubMed
Abstract available

SALMERON-BARCENAS EG, Martinez-Zayas A, Vargas-Mejia M, Villegas-Sepulveda N, et al
DNMT Enzymes and Their Impact on Cervical Cancer: A State-of-the-Art Review.
Int J Mol Sci. 2025;26:10496.
PubMed
Abstract available

PINEDA-MIGRANAS JA, Bravata-Alcantara JC, Cortes-Ortiz IA, Cortes-Malagon EM, et al
Liquid Biopsy Biomarkers for Cervical Cancer: A Systematic Review.
Int J Mol Sci. 2025;26:10503.
PubMed
Abstract available

OZKAYA UCAR Y, Aytekin O, Yalcin N, Oktar O, et al
Survival Outcomes and Prognostic Factors for Patients in Early Stage Cervical Cancer: A Multicentric Study in Turkey.
Diagnostics (Basel). 2025;15:2757.
PubMed
Abstract available

SITTIWONG W, Prasartseree T, Tuntapakul P, Thaweerat W, et al
Re-irradiation in oligorecurrence and oligometastatic cervical cancer in modern radiotherapy era.
Radiat Oncol. 2025;20:168.
PubMed
Abstract available

HUANG W, Liu T, Shen Y, Xiang Z, et al
Automatic radiotherapy planning for deliverable plans using deep learning dose prediction and dose rings optimization in cervical cancer.
J Appl Clin Med Phys. 2025;26:e70353.
PubMed
Abstract available

DANG T, You Y, Wei L, Li Q, et al
Corrigendum to "ICAT drives lactylation of tumor-associated macrophages via the c-Myc-ENO1 axis to promote cervical cancer progression" [Free Radic. Biol. Med. 241 (2025) 316-329].
Free Radic Biol Med. 2025 Nov 11:S0891-5849(25)01337.
PubMed

TATARCHUK T, Kalugina L, Antipkin Y, Tutchenko T, et al
Exploring awareness, attitudes and clinical practices of Ukrainian health professionals regarding human papillomavirus and vaccination: a qualitative study.
BMJ Open. 2025;15:e089968.
PubMed
Abstract available

LIN G, Guo X, Fu Z, Liu Z, et al
Self-amplifying mRNA nanovaccine encoding GM-CSF-fused HPV16 E7 enhances immunogenicity and therapeutic efficacy against cervical cancer.
Int J Biol Macromol. 2025 Nov 10:148933. doi: 10.1016/j.ijbiomac.2025.148933.
PubMed
Abstract available

LI T, Xiong X, Xie T, Liu W, et al
USP13 exacerbates the malignant progression of cervical cancer by inhibiting ECT2 ubiquitination and degradation.
Reprod Biol. 2025;26:101095.
PubMed
Abstract available

NAKAHASHI-OUCHIDA R, Mori H, Yuki Y, Machita T, et al
Cationic nanogel-based nasal therapeutic HPV vaccine prevents the development of cervical cancer.
Sci Transl Med. 2025;17:eado8840.
PubMed
Abstract available

KANDASAMY G, Orayj K, Shorog E, Alshahrani AM, et al
Knowledge and attitudes toward human papillomavirus and cervical cancer prevention among women in the Asir Region, Saudi Arabia: a cross-sectional study.
Front Oncol. 2025;15:1608568.
PubMed
Abstract available

KANDASAMY G, Orayj K, Shorog E, Alshahrani AM, et al
Correction: Knowledge and attitudes toward human papillomavirus and cervical cancer prevention among women in the Asir Region, Saudi Arabia: a cross-sectional study.
Front Oncol. 2025;15:1726725.
PubMed
Abstract available

OUYANG S, Xiong K, Chen P, Liu X, et al
Mechanism of interaction between ANXA6 and cGAS to regulate STING signaling pathway and promote ferroptosis in cervical cancer.
Cancer Cell Int. 2025;25:397.
PubMed
Abstract available

SENTHILKUMAR S, Chitale RA, Kempaiah P, Saraf D, et al
Eliminating Cervical Cancer in India: Challenges and Prospects.
Am J Trop Med Hyg. 2025 Nov 11:tpmd250396. doi: 10.4269/ajtmh.25-0396.
PubMed
Abstract available

CHEN X, Xia S, Han X, Han J, et al
Reproductive concerns in young women with cervical cancer: latent profiles and key influencing factors.
Support Care Cancer. 2025;33:1041.
PubMed
Abstract available

WALDECKER M, Taghavi K, Pasin C, Tarr PE, et al
Factors associated with uptake of gynaecological care and cervical cancer screening among women in the Swiss HIV Cohort Study.
HIV Med. 2025 Nov 11. doi: 10.1111/hiv.70137.
PubMed
Abstract available

ZOUZOULAS D, Chatzistamatiou K, Tsolakidis D
The role of p16/Ki-67 dual staining in cervical cancer screening and cervical precancerous lesions follow-up.
Cytojournal. 2025;22:78.
PubMed

DE PAEPE E, Nanyonjo G, Vermandere H, Ssetaala A, et al
Cervical cancer screening policies and implementation in Uganda - a qualitative study on policymakers', cervical cancer experts' and gynecologists' perspectives.
Arch Public Health. 2025;83:270.
PubMed
Abstract available

NTHAMBI L, Temmerman M, Macharia WM, Nyagol J, et al
Factors associated with cervical cancer screening among women attending maternal child health clinics in Kenya.
BMC Womens Health. 2025;25:549.
PubMed
Abstract available

IKAWA T, Morishima T, Nakata K, Kishimoto K, et al
Trends in radiotherapy use and implementation challenges among patients with cervical cancer: a multicenter study in Osaka, Japan.
J Radiat Res. 2025 Nov 10:rraf066. doi: 10.1093.
PubMed
Abstract available

BUDIANA IN, Prayudi PKA, Mahendra INB, Remitha NPSI, et al
Plasma level of cancer stem cell marker aldehyde dehydrogenase 1 (ALDH1) is higher in locally advance cervical cancer.
Taiwan J Obstet Gynecol. 2025;64:1050-1055.
PubMed
Abstract available

CLAIRE LIN CC, Tai CC, Hung P, Tung YC, et al
Community mobile health clinics' availability is associated with cervical cancer screening in rural and urban areas: A national cohort study in Taiwan.
Taiwan J Obstet Gynecol. 2025;64:1024-1029.
PubMed
Abstract available

XIAN Z, Pang X
STROBE-Cross-Population Mendelian Randomization Analysis of Circulating Inflammatory Proteins and Cervical Cancer Risk in European and Asian Populations.
Crit Rev Immunol. 2025;45:43-51.
PubMed
Abstract available

HUANG Y, Wei X, Guo Y, Su T, et al
Incidence, persistence, and clearance of cervical human papillomavirus infection among gynecological outpatients in Kunming, Yunnan, China, 2019-2023: a retrospective cohort study.
PeerJ. 2025;13:e20215.
PubMed
Abstract available

PAROLA S, Colombo I
Bispecific antibodies in the treatment of epithelial ovarian, endometrial, and cervical cancer: an overview of current applications, challenges, and emerging opportunities.
Explor Target Antitumor Ther. 2025;6:1002345.
PubMed
Abstract available

ARDILA-CHANTRE N, Barragan-Cardenas AC, Reyes-Calderon JE, Franco-Zambrano DS, et al
A Lactoferricin B/Buforin Chimeric Peptide Causes a Rapid, Selective, Prolonged Cytotoxic Effect and Induces Apoptosis in HPV18-Positive Cervical Cancer Cells.
ACS Omega. 2025;10:51143-51157.
PubMed
Abstract available

ZHANG Y, Lu Y, Li S, Zheng F, et al
Precision theranostics in cervical Cancer: Harnessing stimuli-responsive hydrogels for tumor microenvironment-targeted therapy and diagnosis.
Mater Today Bio. 2025;35:102392.
PubMed
Abstract available

KERNELL C, MacDuffie E, Lin X, Gao L, et al
HPV profiles in Botswana: An analysis of healthy women, cervical intraepithelial neoplasia, and invasive cervical cancer.
Gynecol Oncol Rep. 2025;62:101971.
PubMed
Abstract available

HUANG H, Li X, Xu Q, Wu J, et al
Impact of regional lymph node surgery and lymph node status on survival of small cell cervical cancer patients undergoing primary site surgery.
Int J Surg. 2025 Nov 10. doi: 10.1097/JS9.0000000000003870.
PubMed
Abstract available

IKAWA T, Nakata K, Morishima T, Yoshida KI, et al
Secondary Lower-Body Sarcomas in Cervical Cancer Survivors Following Surgery, Radiotherapy, or Both: A Population-Based Study.
Cancer Sci. 2025 Nov 9. doi: 10.1111/cas.70229.
PubMed
Abstract available

LIN W, Lan X, Huang W, Tang S, et al
Preoperative prediction of cervical cancer recurrence using explainable MRI radiomics: a SHAP-Guided machine learning study.
Abdom Radiol (NY). 2025 Nov 10. doi: 10.1007/s00261-025-05261.
PubMed
Abstract available

LIU JJ, Zou JH, Dong B, Lu XP, et al
Inhibitory Effect of TrxR Inhibitor Ag (?) Schiff Base Complex Against Cervical Cancer Via ROS-mediated ASK1/MAPK Signaling and Autophagy.
Biol Trace Elem Res. 2025 Nov 9. doi: 10.1007/s12011-025-04895.
PubMed
Abstract available

FERREIRA P, Hagege M, Tran PL
From policy to practice in cervical cancer prevention in Reunion Island.
J Gynecol Obstet Hum Reprod. 2025 Nov 6:103067. doi: 10.1016/j.jogoh.2025.103067
PubMed

GAN J, Cao D, Zhou H, Yu M, et al
Cervical Adenocarcinoma: What's Special About the Long-Term Reproductive and Oncological Outcomes of Fertility-Sparing Radical Trachelectomy in It?
Cancer Med. 2025;14:e71366.
PubMed
Abstract available

SAHIN G, Ulu FY, Yuksel IT
Predictive determinants of CIN II + lesions in women over 65 years old: the contribution of HPV, colposcopy, and double immunostaining techniques.
BMC Geriatr. 2025;25:855.
PubMed
Abstract available

TSAI YL, Tam KW
Reply to letter to Editor concerning "Impact of COVID-19 on cervical cancer screening: A cohort study".
J Formos Med Assoc. 2025 Nov 6:S0929-6646(25)00590.
PubMed

KIM G, Antaki M, Schmidt EJ, Roumeliotis M, et al
Automatic digitization of applicator and catheters for MRI-guided cervical cancer brachytherapy.
Brachytherapy. 2025 Nov 6:S1538-4721(25)00318.
PubMed
Abstract available

JIANG Q, Xu R, Cheng J, Shi Y, et al
Mechanisms underlying the therapeutic effects of Amygdalin in treating Cervical Cancer based on multi-omics analysis.
J Pharm Biomed Anal. 2025;268:117232.
PubMed
Abstract available

NUNZIATA G, Limiti E, Aramini D, Nava M, et al
pH-Thermo Dual-Responsive Polymeric Nanoparticles for Women's Health: Dual Action Against Cervical and Ovarian Cancer Cells.
ACS Appl Mater Interfaces. 2025;17:61888-61904.
PubMed
Abstract available

KEAM SJ
Famitinib: First Approval.
Drugs. 2025;85:1613-1620.
PubMed
Abstract available

LIU Q, Wiese D, Pinheiro PS, Bispo JB, et al
Association between racialized economic segregation and stage at diagnosis for 3 screenable cancers in New York City.
J Natl Cancer Inst. 2025;117:2259-2271.
PubMed
Abstract available

HIDAYATI NR, Endarti D, Setiawan D
Cost-Utility Analysis of Expanding Human Papillomavirus Vaccination to Adult Women in Indonesia: A Markov Model Approach.
Value Health Reg Issues. 2025;50:101147.
PubMed
Abstract available

KAMATE B, Kassogue Y, Diakite B, Traore B, et al
Distribution of High-Risk Human Papillomavirus in Self-Collected Cervicalvaginal Samples from the General Malian Population.
Biochem Genet. 2025;63:5053-5066.
PubMed
Abstract available

ZHANG Z, Li B, Li W, Wang Z, et al
The relationship between CTCs, TFD and postoperative prognosis of cervical cancer patients and the construction of prediction models.
Sci Rep. 2025;15:41307.
PubMed
Abstract available

BEGUM D, Bassetty KC, Barmon D, Baruah U, et al
Determinants of delay in presentation to completion of treatment in cervical cancer.
Sci Rep. 2025;15:41329.
PubMed
Abstract available

GUY MM, Mao Z, Yu Y, Liu Y, et al
Development and validation of the risk stratification based on deep learning and radiomics to predict survival of advanced cervical cancer.
Sci Rep. 2025;15:41202.
PubMed
Abstract available

WANG S, Liu X, Wang Z, Pan Y, et al
Mr-based radiomics analysis of intra-tumor heterogeneity for early treatment response prediction in locally advanced cervical cancer treated with concurrent chemoradiotherapy.
Eur J Radiol. 2025;194:112547.
PubMed
Abstract available

MERTELSMANN AM, Maganga JK, Lee MH, Ward M, et al
Schistosoma haematobium infection is associated with oncogenic gene expression in Cervical Mucosa, with enhanced effects following treatment: A pilot study.
PLoS Negl Trop Dis. 2025;19:e0013569.
PubMed
Abstract available

SHETTY S, Prasada Kabekkodu S
Protocol for investigating mitochondrial structure, function, and metabolism in human cervical cancer cells.
STAR Protoc. 2025;6:104202.
PubMed
Abstract available

PIYA IJ, Riya IJ, Sharma V
Efficacy and safety of immune checkpoint inhibitors with chemoradiotherapy/chemotherapy in locally advanced cervical cancer patients: a systematic review and single-arm meta-analysis.
J Gynecol Oncol. 2025 Oct 24. doi: 10.3802/jgo.2026.
PubMed
Abstract available

LURGAIN JG, Peremiquel-Trillas P, Ouaarab-Essadek H, Mellouki K, et al
Moroccan and Pakistani women's knowledge and perceptions on cervical cancer screening and HPV self-sampling acceptability in Catalonia, Spain: a mixed-methods study.
BMC Health Serv Res. 2025;25:1502.
PubMed
Abstract available

KUMARI K, Gupta RK, Kumar S, Prasad SB, et al
Genes associated with epithelial mesenchymal transition (EMT) in cervical cancer progression.
Discov Oncol. 2025 Nov 20. doi: 10.1007/s12672-025-04011.
PubMed
Abstract available

XIANG M, Yu Y, Gao Q, Xing J, et al
MiR-425-5p Mediation of Malignant Behavior and Immune Escape of Cervical Cancer Cells by Targeting NCAM1.
Iran J Allergy Asthma Immunol. 2025;24:834-850.
PubMed
Abstract available

LIRA GA, de Azevedo FM, Lins IGS, Crispim JCO, et al
FOXP3 Polymorphism and Upregulation of the CXCL12-CXCR4-SNAIL Axis with High Infiltration of M2TAM by STAT3/NFKB Pathways Influence the Survival of Cervical Cancer Patients.
Adv Biol (Weinh). 2025 Nov 20:e00354. doi: 10.1002/adbi.202500354.
PubMed
Abstract available

MEDA S, Musunuri B, Shetty S, Udupa K, et al
A Rare Metastasis to the Stomach From Cervical Cancer: A Case Report and Review of the Literature.
Cureus. 2025;17:e94889.
PubMed
Abstract available

NEISI N, Mousavikish F, Bastani MN, Parsanahad M, et al
Impact of High-Risk HPV Infection on PI3K, MALAT1, H19 and LINC00460 Expression in Cervical Cells.
J Cell Mol Med. 2025;29:e70949.
PubMed
Abstract available

CAO G, Wang Y, Zeng H, Zhi Y, et al
Oligoclonal tumor-specific CD8 T-cell revival and IRE1alpha/XBP1-GDF15-mediated immunosuppressive niches determine neoadjuvant chemoimmunotherapy efficacy in cervical cancer.
J Immunother Cancer. 2025;13:e012630.
PubMed
Abstract available

NI Y, Zhou X, Tang Y, Ren W, et al
SB225002 Enhances Radiosensitivity in Cervical Cancer via Direct Neutrophil Inhibition and Tumor Cell Suppression.
Cancer Lett. 2025 Nov 17:218153. doi: 10.1016/j.canlet.2025.218153.
PubMed
Abstract available

PAZ-SOLDAN VA, Nussbaum L, Brown J, Meza-Sanchez G, et al
A realist evaluation of a novel cervical cancer prevention strategy in Iquitos, Peru.
PLOS Glob Public Health. 2025;5:e0004517.
PubMed
Abstract available

BESO DELGADO M, Ibanez Cabanell J, Castan Cameo S, Mira Solves JJ, et al
Optimisation of a Cervical Cancer Screening Model Based on Self-Sampling for Human Papillomavirus Testing.
Cancer Control. 2025;32:10732748251378812.
PubMed
Abstract available

ZHANG J, Jin LF, Jia C, Zhang HP, et al
Assessing Local Invasion in Cervical Cancer: The Diagnostic Performance of Transrectal Contrast-Enhanced Ultrasonography.
Br J Radiol. 2025 Nov 19:tqaf283. doi: 10.1093.
PubMed
Abstract available

SUN W, Liu Q, Hao Y, Liu Y, et al
Development and validation of a deep learning model for individualized survival prediction in advanced cervical cancer.
Discov Oncol. 2025 Nov 18. doi: 10.1007/s12672-025-03920.
PubMed
Abstract available

RANGA S, Yadav R, Chauhan MB, Chauhan P, et al
Molecular and bioinformatics analysis of long non-coding RNAs in cervical cancer.
Chromosoma. 2025;134:11.
PubMed
Abstract available

XING W, Wang Z, Zhu Y, Ge G, et al
Prognostic value of combining nutritional inflammatory index trajectories and tumor characteristics in cervical cancer.
BMC Womens Health. 2025;25:567.
PubMed
Abstract available

SINGH G, Dash NR, Shaju A, Chakkalakkunnan SS, et al
Perceptions and sentiments associated with HPV vaccine uptake among Indian Reddit users: a qualitative social media analysis.
BMC Public Health. 2025;25:4037.
PubMed
Abstract available

ZHOU W, Wang Y, Long H, Wang J, et al
Construction of a Nomogram Prediction Model for Individualized Prediction of Cervical Cancer Risk: A Retrospective Study.
Int J Womens Health. 2025;17:4435-4446.
PubMed
Abstract available

SUN Y, Zhou F, Zhong X, Lv X, et al
Hippo signaling pathway in cervical cancer: insights into mechanisms and therapeutic potential.
Front Oncol. 2025;15:1662499.
PubMed
Abstract available

WANG R, Liu B, Wei SW, Liu YR, et al
Meta-analysis of factors influencing depression in cervical cancer patients.
Front Public Health. 2025;13:1657690.
PubMed
Abstract available

D'AMBROSIO F, Sezzatini R, Bucciardini R, Maida A, et al
Educational interventions and communication strategies to improve HPV immunization uptake: a systematic literature review.
Front Public Health. 2025;13:1675946.
PubMed
Abstract available

ZHU L, Li P, Wang Y, Zhang S, et al
The relationship between human papillomavirus genotype distribution and age and the association with high-grade squamous intraepithelial lesions of the cervix or cervical cancer in Jilin Province, China.
Virol J. 2025;22:380.
PubMed
Abstract available

YUAN ZL, Shi DW, Guan H, Liu F, et al
MRI cytometry imaging for cervical cancer differential diagnosis: a preliminary study.
BMC Med Imaging. 2025;25:474.
PubMed
Abstract available

NEVILLE C, Reese S, Hughes B, Glennon K, et al
Age, lifestyle, and disease affect ciliary transport in the human fallopian tube.
Sci Rep. 2025;15:40594.
PubMed
Abstract available

KARTHIKEYAN P, Malaserene I, Deepakraj E
Explainable AI based cervical cancer prediction using FSAE feature engineering and H2O AutoML.
Sci Rep. 2025;15:40439.
PubMed
Abstract available

LEBRET D, Lafond C, Leseur J, Barateau A, et al
Prospective multi-institutional study of library-based adaptive radiotherapy for cervical cancer: Evaluation of plan-of-the-day selection and population analysis.
J Appl Clin Med Phys. 2025;26:e70356.
PubMed
Abstract available

TOHYA T, Ozono K
[Occurrence of Malignant Peritoneal Mesothelioma 19 Years after Concurrent Chemoradiation Therapy for Uterine Cervical Cancer Stage ?B-A Case Report and Literature Review].
Gan To Kagaku Ryoho. 2025;52:823-824.
PubMed
Abstract available

LI X, Qin X, Zhao X, Liu Y, et al
Spatial multi-omics guides ASCT2-targeted delivery of glycolysis inhibitor for cervical cancer suppression and chemoresistance reversal.
J Adv Res. 2025 Nov 16:S2090-1232(25)00931-2. doi: 10.1016/j.jare.2025.
PubMed
Abstract available

DO CARMO TM, Borba MACSM, de Mendonca Batista P, Rego MADC, et al
Real-World Data on Cervical Cancer: The Impact of 2020 COVID-19 Outbreak on the Treatment Patterns and Healthcare Resources Utilization in Brazilian Public Health System.
Value Health Reg Issues. 2025;52:101508.
PubMed
Abstract available

PARUCHURI B, Miller A
Gynecologic Cancers: Cervical Cancer.
FP Essent. 2025;558:6-14.
PubMed
Abstract available

HE Y, Hou J, Deng Y, Huang R, et al
CircUSP36 promotes FBXO5 expression to accelerate cervical cancer progression by targeting miR-520d-5p.
Cytotechnology. 2025;77:197.
PubMed
Abstract available

M D A, B V
SegResDeiT: a hybrid SegNet-ResNet-50-DeiT framework for automated cervical cancer segmentation and classification.
BMC Med Imaging. 2025;25:469.
PubMed
Abstract available

ROMERO D
Sentinel lymph node biopsy improves surgical management of cervical cancer.
Nat Rev Clin Oncol. 2025 Nov 17. doi: 10.1038/s41571-025-01107.
PubMed

WAPMUK AE, Obionu I, Obiezu-Umeh C, Gbaja-Biamila TA, et al
Intersectional stigma and resilience in the uptake of cervical cancer prevention services in Nigeria: a qualitative study.
BMJ Glob Health. 2025;10:e020065.
PubMed
Abstract available

WANG M, Zou X, Wang Z
Meta-analysis about correlation between the human Papillomavirus infection and the incidence of cervical intraepithelial Neoplasia.
J Pak Med Assoc. 2025;75.
PubMed
Abstract available

SU L, Zhang J, Yao J, Ren Y, et al
ADCs in cervical cancer: current clinical trial landscape and future prospects.
Int J Surg. 2025 Nov 17. doi: 10.1097/JS9.0000000000003732.
PubMed

ALGHAMDI R, Alghamdi M, Farsi N, Alyafi M, et al
Knowledge of the human papilloma virus and acceptance of its vaccine among male and female young adults in Jeddah, Saudi Arabia: A cross-sectional study.
Hum Vaccin Immunother. 2025;21:2583609.
PubMed
Abstract available

MUZZARELLI A, Paderno M, Lorusso D
New developments in the treatment of cervical cancer in 2026.
Curr Opin Obstet Gynecol. 2025 Nov 18. doi: 10.1097/GCO.0000000000001079.
PubMed
Abstract available

REDROBAN JDS, Lopez D, Santillan C
A Narrative Review of Human Papillomavirus (HPV) Vaccination in Ecuador: A Crisis of Inequity and an Evidence-Based Roadmap for Elimination.
J Epidemiol Glob Health. 2025;15:135.
PubMed
Abstract available

ZHOU X, An R, Li X
Cervical cancer immune microenvironment: Mechanisms of HPV-mediated immune evasion and advances in immunotherapy (Review).
Oncol Lett. 2025;31:22.
PubMed
Abstract available

KLIMOV-KRAVTCHENKO K, Baltazar-Diaz TA, Haramati J, Castano-Jimenez PA, et al
Microbiota-immune dysregulation in cervical cancer patients from Western Mexico: linking gut dysbiosis and NK cell exhaustion as promising biomarkers.
Front Immunol. 2025;16:1637098.
PubMed
Abstract available

GUO R, Chai O, Li C, Xu Y, et al
B7 homolog 6 promotes the killing activity of natural killer cells against cervical cancer through the downstream ERK pathway of NKp30.
Transl Cancer Res. 2025;14:6536-6550.
PubMed
Abstract available

KHUNTSARIA I, Gachechiladze K, Liparta E, Kobulashvili T, et al
Strategic implementation of HPV vaccination to eliminate cervical cancer in Georgia.
Public Health Pract (Oxf). 2025;10:100679.
PubMed
Abstract available

WANG Y, Gan N, Ning S, Qiu Y, et al
Prognostic value and early response stratification of a multi-biomarker panel in cervical cancer patients undergoing chemoradiotherapy.
Front Oncol. 2025;15:1686716.
PubMed
Abstract available

SHAMSI U, Saleem S, Usman N, Azam I, et al
Late-stage diagnosis and its impact on survival in Pakistani women with cervical cancer: Findings from an institutional cancer registry.
Pak J Med Sci. 2025;41:2709-2714.
PubMed
Abstract available

WANG X, Wang F, Yang W, Li Y, et al
Exploring the significance of GNG11, LPAR1, and AGTR1 in early diagnosis and prognosis of cervical cancer: A correlative analysis with clinical characteristics.
Pak J Med Sci. 2025;41:2776-2783.
PubMed
Abstract available

ATIF M
Human Papillomavirus (HPV) and Cervical Cancer: A Call to action for Pakistan.
J Pak Med Assoc. 2025;75:1686-1687.
PubMed

AHSAN S
Single dose HPV (Human Papilloma Virus) Vaccination for Cervical Cancer Prevention in Pakistan.
J Pak Med Assoc. 2025;75:1519-1521.
PubMed

MASOOD S, Sharad P, Kushwah AS, Masood O, et al
MicroRNAs and HPV oncogenes crosstalk, their biomarker potential and therapeutic utility in cervical cancer.
Biomark Med. 2025 Nov 17:1-13. doi: 10.1080/17520363.2025.2590779.
PubMed
Abstract available

LI H, Li X, Zhang J, Dai Y, et al
AI-assisted 3D-printed transvaginal template guidance for interstitial brachytherapy in patients with cervical cancer with parametrial invasion.
Brachytherapy. 2025 Nov 15:S1538-4721(25)00355.
PubMed
Abstract available

WANG D, Duan Z, Chen M, Li W, et al
Oncogenic GINS1 facilitates cervical cancer progression via FYN-mediated EMT regulation.
Life Sci. 2025 Nov 14:124090. doi: 10.1016/j.lfs.2025.124090.
PubMed
Abstract available

LI J, Li J, Chen X
Oncogenic role of PLOD3 mediated by SOX9 through IL-6/JAK/STAT3 pathway in cervical cancer.
Cell Signal. 2025;138:112250.
PubMed
Abstract available

ENGLER T, Nagele M, Dannehl D, Englisch A, et al
Management and natural course of CIN 1 and CIN 2 before and after implementation of the revised cervical cancer screening in Germany.
Arch Gynecol Obstet. 2025 Nov 16. doi: 10.1007/s00404-025-08190.
PubMed
Abstract available

JHAVAR S, Gomber G, Patel M, Klopp A, et al
Exploring access to brachytherapy for cervical cancer in Texas: Geographic availability and distribution.
Brachytherapy. 2025 Nov 14:S1538-4721(25)00307.
PubMed
Abstract available

BENARD E, Drolet M, Gingras G, Laprise JF, et al
Ranking the most efficient human papillomavirus vaccination strategies in low-income and lower-middle income countries: a mathematical modelling analysis.
Lancet Glob Health. 2025;13:e2153-e2164.
PubMed
Abstract available

NIU H, Zheng J, Xie N, Jiang C, et al
Discriminant study of cervical squamous cells based on computer image analysis.
Medicine (Baltimore). 2025;104:e45630.
PubMed
Abstract available

LYU W, Hu S, Li J
Brachytherapy facilitates closure of malignant vesicovaginal fistulas: A case report and literature review.
Medicine (Baltimore). 2025;104:e44708.
PubMed
Abstract available

WANG S, Zhu P
Expression and clinicopathological significance of KAI1, MACC1, and AGR2 in cervical squamous cell carcinoma.
Medicine (Baltimore). 2025;104:e45992.
PubMed
Abstract available

HOU Z, Tang G, Chu H, Wang Z, et al
Machine learning-based screening and validation of pyroptosis-associated prognostic genes and potential drugs in cervical cancer.
BMC Med Genomics. 2025;18:183.
PubMed
Abstract available

SHI Y, Sun N, Ren J, Sun J, et al
Vaccination Strategies against HPV Infection and Cervical Cancer in China: A Transmission Modeling Study.
Med Decis Making. 2025 Nov 14:272989X251388915. doi: 10.1177/0272989X251388915.
PubMed
Abstract available

CHANG L, Kang Y, Zhuo Y, Liu J, et al
Comprehensive clinical analysis of gastric-type endocervical adenocarcinoma: a real-world multicenter study.
Ann Med. 2025;57:2584735.
PubMed
Abstract available

XIE Z, Shen T, Wang Y, Ma R, et al
RNA sequencing and bioinformatics analysis have identified MAST1 as a potential biomarker and therapeutic target for cervical cancer.
Transl Cancer Res. 2025;14:7157-7169.
PubMed
Abstract available

CHEN X, Hong C, Zhang G, Lin B, et al
Cervical cancer molecular subtype identification and prognosis classification by a metabolism-related gene expression.
Transl Cancer Res. 2025;14:6207-6221.
PubMed
Abstract available

XU B, Shi X, Liu Y, Xu L, et al
CC/CXC chemokine risk signature at single-cell resolution: a machine learning model for precision stratification in cervical cancer.
Transl Cancer Res. 2025;14:6834-6848.
PubMed
Abstract available

WU Z, Zhang J, Sun B, Wu Y, et al
Construction and verification of a prognostic model for cervical cancer based on genes associated with the p53 regulatory pathway.
Transl Cancer Res. 2025;14:6738-6757.
PubMed
Abstract available

BENJAWAN L, Sathalalai P, Promdaeng S, Sukkhung S, et al
Supercritical CO(2) extraction of Clinacanthus nutans: Enhanced bioactive recovery and cytotoxicity against cervical cancer cells.
J Adv Pharm Technol Res. 2025;16:235-241.
PubMed
Abstract available

BDAY J, Souid M, Farhat KH, Macherki Y, et al
Involvement of endothelial nitric oxide synthase (eNOS) and nitric oxide (NO) levels in precancerous and cancerous cervical lesions.
Nitric Oxide. 2025;159:176-185.
PubMed
Abstract available

HASHIDA Y, Matsumoto S, Maeda N, Teshima M, et al
Detection of partial deletions of the human papillomavirus 16 E6 gene in a subset of oropharyngeal and cervical cancers.
Virus Res. 2025;361:199648.
PubMed
Abstract available

ALLEMANI C, Minicozzi P, Morawski B, Lima CA, et al
Global variation in patterns of care and time to initial treatment for breast, cervical, and ovarian cancer from 2015 to 2018 (VENUSCANCER): a secondary analysis of individual records for 275 792 women from 103 population-based cancer registries in 39
Lancet. 2025 Oct 22:S0140-6736(25)01383-2. doi: 10.1016/S0140-6736(25)01383.
PubMed
Abstract available

PEDREANEZ A, Carrero Y, Vargas R, Fonseca JPH, et al
Role of C-reactive protein in cervical intraepithelial neoplasia/cancer.
Pathol Res Pract. 2025;276:156274.
PubMed
Abstract available

AGRAWAL R, Shetake N, Verma G, Pandey BN, et al
Nanoarchitectures of Folate-Functionalized Highly Monodispersed Ce-Tb Doped Core@Shell Nanorods for Targeted and Enhanced Chemotherapy of Human Cervical and Triple-Negative Breast Carcinoma.
ACS Appl Bio Mater. 2025;8:10006-10023.
PubMed
Abstract available

CHEN G, Wang M, Lin E, Zheng N, et al
Herbal medicines for radiation vaginitis: A systematic review and meta-analysis.
Phytomedicine. 2025;148:157367.
PubMed
Abstract available

KIM SK, Duncan R, Chittams J, Teitelman AM, et al
Evaluating Now I Know mHealth intervention promoting HPV vaccine completion among young women attending federally supported clinics.
Cancer Causes Control. 2025;36:1989-2000.
PubMed
Abstract available

MURPHY KM, Weatherhead K, Chenault C, Nguyen C, et al
Impact of the Genius Digital Diagnostics System on workflow and accuracy compared with the ThinPrep Imaging System for review of ThinPrep Papanicolaou tests.
Am J Clin Pathol. 2025;164:746-751.
PubMed
Abstract available

JANIO E, Kahl AR, Kpozehouen D, Askelson N, et al
Association of distance to diagnosis and area-based social measures with stage at diagnosis among Iowans with HPV-related cancers.
Cancer Causes Control. 2025;36:1881-1890.
PubMed
Abstract available

YE Z, Zhang P, Wei R, Niu H, et al
Deep Learning-Assisted System Improves Practical Effects in Cervical Cytopathology Diagnosis: A Comparative Study of Reading Modes.
Mod Pathol. 2025;38:100882.
PubMed
Abstract available

KIRSCHE L, Jansen L, Petzold A, Reinecke P, et al
Heterogeneous Distribution of Human Papillomavirus (HPV) Integration Sites in Cervical Precancers Compromises the Diagnostic Accuracy of Integrant-Specific PCR.
Lab Invest. 2025;105:104232.
PubMed
Abstract available

PALMER KNB, Mantina NM, Adegboyega A, Sokale IO, et al
Group concept mapping to develop a salon-based HPV self-collection intervention.
Cancer Causes Control. 2025;36:1753-1762.
PubMed
Abstract available

GANGULY AP, DeWalt DA, Brenner AT, Reuland DS, et al
Child caregiving and cancer screening: a nationally representative analysis.
Cancer Causes Control. 2025;36:1731-1741.
PubMed
Abstract available

TIITI TA, Aluko O, Barrett C
Knowledge of human papillomavirus and self-sampling, including vaccination practices among female students in Free State, South Africa.
Cancer Causes Control. 2025;36:1705-1717.
PubMed
Abstract available

WANG G, Liu X, Si Z, Wang Z, et al
A Scallop-shaped Photopenic Region in the Urinary Bladder Area on Tc-99m MDP Bone Scan Caused by a Uterine Cervical Leiomyoma.
Clin Nucl Med. 2025;50:1243-1244.
PubMed
Abstract available

ASWOLINSKIY W, van der Post RS, Campora M, Baronchelli C, et al
Attention-Based Whole-Slide Image Compression Achieves Pathologist-Level Prescreening of Multiorgan Routine Histopathology Biopsies.
Mod Pathol. 2025;38:100827.
PubMed
Abstract available

TAY SK, Wastlund D, Sim RSY, Karichu J, et al
Cost-effectiveness analysis of reflex p16/Ki-67 dual-stained cytology in HPV partial genotyping screening in Singapore.
J Gynecol Oncol. 2025;36:e115.
PubMed
Abstract available

ADEFEMI K, Knight JC, Zhu Y, Wang PP, et al
Concurrent cancer screening participation and associated factors among Canadian women: Insights from a cross-sectional study.
J Med Screen. 2025;32:205-214.
PubMed
Abstract available

BAEK JY, Kim HS, Cho WK, Kim BG, et al
Significance of HPV status on tumor response and treatment outcomes in endocervical adenocarcinoma treated with definitive chemoradiotherapy: a retrospective study.
J Gynecol Oncol. 2025;36:e92.
PubMed
Abstract available

GORI S, Venturelli F, Carozzi F, Giorgi Rossi P, et al
Correction: Italian guidelines for cervical cancer screening. Multisocietal recommendations on the use of biomarkers in HPV screening with risk-based approach and GRADE methodology.
Br J Cancer. 2025 Nov 11. doi: 10.1038/s41416-025-03250.
PubMed

YE Z, Zhao Y, Wang J, Wang Q, et al
Pooled performance of urinary human papillomavirus (HPV) testing for the presence of cervical HPV.
Cancer. 2025;131:e70175.
PubMed
Abstract available

FERREIRA JE, Chiang N, Jing X, Smola B, et al
In-Depth Assessment of Cytologic Features in 106 Cervical Papanicolaou Tests of Transgender Male Patients on Testosterone: An Institutional Experience.
Diagn Cytopathol. 2025 Sep 15. doi: 10.1002/dc.70018.
PubMed
Abstract available

ETTORRE VM, Demirkiran C, Bellone S, Hartwich TMP, et al
Effective preclinical activity of datopotamab deruxtecan (Dato-DXd), an ADC targeting trophoblast cell-surface antigen 2 (TROP2), against primary cervical carcinoma cell lines and xenografts.
Gynecol Oncol. 2025;201:195-202.
PubMed
Abstract available

BAO W, He X, Huang Y, Xing A, et al
Effect of uterine manipulator on stage IB1 to IIA1 cervical cancer: A retrospective cohort study.
Gynecol Oncol. 2025;204:27-36.
PubMed
Abstract available

SA P, Monteiro P, Henrique R, Lunet N, et al
The cervical cancer screening program in the North of Portugal: Outcomes after nearly two decades of coexistence with the human papillomavirus vaccine.
Int J Cancer. 2025 Nov 3. doi: 10.1002/ijc.70196.
PubMed
Abstract available

ANDERSEN K, Bonde J, Waldstrom M, Jakobsen MV, et al
Evaluation of targeted next-generation sequencing for detection of HPV genotypes and sublineages in cervical liquid-based cytology SurePath samples from the Danish screening program.
Int J Cancer. 2025 Sep 11. doi: 10.1002/ijc.70148.
PubMed
Abstract available

ORTEGA LLOBET M, Gray P, Baussano I, Elfstrom KM, et al
Controlled trial of cervical cancer screening frequency among human-papillomavirus-vaccinated women.
Int J Cancer. 2025 Nov 7. doi: 10.1002/ijc.70229.
PubMed
Abstract available

MARSHALL A, Pareja R, Ruzindana K, Bhatla N, et al
FIGO position statement on the effectiveness and safety of the HPV vaccine.
Int J Gynaecol Obstet. 2025 Sep 3. doi: 10.1002/ijgo.70506.
PubMed
Abstract available

FUJITA H, Okamoto K, Kato H, Watari H, et al
Combination of transvaginal ultrasound with cervical cancer screening contributes to early detection of ovarian cancer: Clinical trial.
Int J Gynaecol Obstet. 2025 Nov 3. doi: 10.1002/ijgo.70599.
PubMed
Abstract available

HINOJOSA-GONZALEZ DE, Escarcega-Bordagaray JA, Murillo-Torres RM, Torres-Martinez M, et al
Immune checkpoint therapy in locally advanced, persistent, recurrent, and metastatic cervical cancer: A systematic review and Bayesian network meta-analysis.
Int J Gynaecol Obstet. 2025 Nov 15. doi: 10.1002/ijgo.70648.
PubMed
Abstract available

WANG L, Wei Y, Wu Q
Correspondence on "Prognostic impact of para-aortic surgical staging in stage IIIC1 cervical cancer according to the FIGO 2018 classification" by El-Baz et al.
Int J Gynecol Cancer. 2025 Oct 4:102706. doi: 10.1016/j.ijgc.2025.102706.
PubMed

EL-BAZ E, Ouldamer L, Touboul C, Lavoue V, et al
Prognostic impact of para-aortic surgical staging in stage IIIC1 cervical cancer according to the FIGO 2018 classification.
Int J Gynecol Cancer. 2025;35:102675.
PubMed
Abstract available

CERDA V, Rimel BJ, Mercer J, Thompson MA, et al
Exploratory evaluation of the somatic and immunologic landscape of primary and metastatic cervical cancer to better inform future clinical trial development.
Int J Gynecol Cancer. 2025;35:102677.
PubMed
Abstract available

WRIGHT JD, Bizzarri N, Agarwal J, Chen L, et al
Association of sentinel lymph node biopsy and isolated tumor cells in cervical cancer.
Int J Gynecol Cancer. 2025 Oct 11:102721. doi: 10.1016/j.ijgc.2025.102721.
PubMed
Abstract available

SHANG X, Qiu L, Liu Y, Chen H, et al
Role of the novel optoelectronic imaging tracing system in cervical cancer screening: preliminary outcomes of a multi-center study.
Int J Gynecol Cancer. 2025;35:102716.
PubMed
Abstract available

BAIOCCHI G, Zanvettor PH, Lopes A, Ribeiro R, et al
Reconsidering adjuvant radiotherapy in intermediate-risk cervical cancer: findings from the CIRCOL study group.
Int J Gynecol Cancer. 2025;35:102723.
PubMed
Abstract available

O'HARA CA, Khoo ZKH, Dimech C, Chong NZ, et al
Screening of human papilloma virus-related anogenital cancers in immunocompromised women: a systematic review of clinical practice guidelines.
Int J Gynecol Cancer. 2025;35:102131.
PubMed
Abstract available

FARZANEH F, Dastyar F, Mohammadi M, Hosseini MS, et al
Long-term oral contraceptive use as a risk factor for high-grade cervical lesions in women with high-risk human papillomavirus: a retrospective cohort analysis.
Int J Gynecol Cancer. 2025;35:102650.
PubMed
Abstract available

MATSUO K, Matsuzaki S, Roman LD
Definition of intermediate risk cervical cancer and histology-specific survival interaction.
Int J Gynecol Cancer. 2025 Oct 17:102749. doi: 10.1016/j.ijgc.2025.102749.
PubMed

MANNING-GEIST BL, Miller M, Dagher C, Kim SH, et al
Evaluation of toxicity after radical hysterectomy or trachelectomy and post-operative pelvic intensity-modulated radiation therapy with concurrent chemotherapy for cervical cancer.
Int J Gynecol Cancer. 2025;35:102712.
PubMed
Abstract available

MASCILINI F, Mburu A, Ciancia M, Moro F, et al
Diagnostic performance of ultrasound-guided biopsy for detecting recurrent or persistent cervical cancer after chemoradiotherapy: a prospective, single-center study.
Int J Gynecol Cancer. 2025;35:102752.
PubMed
Abstract available

PERALTA J, Caicedo L, Rodriguez J, Viveros-Carreno D, et al
Oncological impact of pelvic vessels embolization in patients with locally advanced cervical cancer treated with concomitant chemoradiotherapy.
Int J Gynecol Cancer. 2025;36:102776.
PubMed
Abstract available

MAMEDE I, Riya IJ, Piya IJ, Nohmi RL, et al
Adjuvant, neoadjuvant, and surgical treatment for locally advanced cervical cancer: a Bayesian network meta-analysis.
Int J Gynecol Cancer. 2025;36:102750.
PubMed
Abstract available

PENG Y, Chen M, Liang T, Wang Y, et al
Distribution and maturity of tertiary lymphoid structures predict recurrence-free survival in cervical cancer.
Int J Gynecol Cancer. 2025;36:102718.
PubMed
Abstract available

SON Y, Hong S, Jang W, Kim S, et al
Global, regional, and national burden of cervical cancer in 2022 and projections to 2050: a population-based analysis of GLOBOCAN.
Int J Gynecol Cancer. 2025;36:102751.
PubMed
Abstract available

HU HP, Leung E
Target Modification and Brachytherapy: Considerations When Radiating Cervical Cancer With a Pelvic Kidney.
Int J Radiat Oncol Biol Phys. 2025;123:1215.
PubMed

YOUNG S, D'Souza DP
Treating Cervical Cancer in a Patient With Pelvic Kidney: Navigating a Narrow Therapeutic Window.
Int J Radiat Oncol Biol Phys. 2025;123:1213-1214.
PubMed

YAN P, Dong Y, Zhang F, Zhen T, et al
Claudin18.2 expression and its clinicopathological feature in adenocarcinoma from various parts.
J Clin Pathol. 2025;78:815-821.
PubMed
Abstract available

LIU S, Pan X, Yang Q, Wen L, et al
[Retracted] MicroRNA?18a enhances the radiosensitivity of cervical cancer cells by promoting radiation?induced apoptosis.
Oncol Rep. 2026;55:18.
PubMed
Abstract available

ABUBAKAR BG
Taking it to their doorstep: outreach well-woman clinics in brothels for cervical cancer screening of female sex workers in North-Western Nigeria.
BMC Cancer. 2025;25:1660.
PubMed
Abstract available

LI N, Yu Z, Li X, Gao Y, et al
The rationality of negative margin criteria for conization in early cervical cancer - a cohort study.
BMC Cancer. 2025;25:1640.
PubMed
Abstract available

ZHOU Y, Guo X, Han J, Ding W, et al
DDR1 drives cervical cancer progression and immune evasion: a bioinformatics analysis with experimental verification.
BMC Cancer. 2025;25:1716.
PubMed
Abstract available

DOFUTSU M, Aichi M, Itai T, Shinoda S, et al
Peripheral lymphocyte count as a prognostic marker in cervical cancer patients treated with immune checkpoint inhibitors: a retrospective study.
BMC Cancer. 2025;25:1762.
PubMed

VENGHATERI JB, Nathani P, Goyal S, Sarang B, et al
Low participation in cancer screening in India: a scoping review of breast and cervical cancer programs.
BMC Cancer. 2025;25:1724.
PubMed
Abstract available

BARDOE D
Predictors of non-screening for cervical cancer in Ghana: an application of Andersen's behavioural model of health services use among pregnant women in Pru East municipality.
BMC Cancer. 2025;25:1783.
PubMed
Abstract available

YANG S, Liu L, Su Q, Wang J, et al
Construction of a prognostic prediction model for concurrent radiotherapy in cervical cancer using GEO and TCGA databases with preliminary validation analysis.
PLoS One. 2025;20:e0334281.
PubMed
Abstract available

SHIN HJ, Joo J, Yoon JH, Yoo CW, et al
Correction: Physical Status of Human Papillomavirus Integration in Cervical Cancer Is Associated with Treatment Outcome of the Patients Treated with Radiotherapy.
PLoS One. 2025;20:e0335489.
PubMed
Abstract available

YOUNAS S, Malik ZI, Khan MU, Manzoor S, et al
Identification of novel therapeutic inhibitors against E6 and E7 oncogenes of HPV-16 associated with cervical cancer.
PLoS One. 2025;20:e0323595.
PubMed
Abstract available

BEN TAHER Y, Ben Rekaya M, Romdhane E, Miladi B, et al
HPV testing in cervical cancer formalin-fixed paraffin embedded tissues: Reliability of the Xpert HPV test and high-risk HPV genotypes distribution in Tunisia.
PLoS One. 2025;20:e0333600.
PubMed
Abstract available

ORENGO JC, Bierrenbach AL, Aranda Flores CE, Lopez ED, et al
Trends in the burden of HPV-associated cancers in Mexico: An analysis from 2011 to 2019.
PLoS One. 2025;20:e0335307.
PubMed
Abstract available

CHEN J, Hong J, Chen K, Zhang X, et al
Dosimetric divergence in ICBT vs. IC/ISBT configurations: Comparative analysis of three optimization algorithms for cervical cancer brachytherapy.
PLoS One. 2025;20:e0335405.
PubMed
Abstract available

DONKOH ET, Abdul IW, Ahiakpa AK, Williams I, et al
Protocol for a systematic review and meta-analysis of the impact of cervical cancer prevention initiatives in Ghana.
PLoS One. 2025;20:e0337011.
PubMed
Abstract available

HALVORSON-FRIED SM, Higgins ICA, Gilkey MB, Lazard AJ, et al
Perceived effectiveness of messages to address cervical cancer screening barriers: An online experiment.
PLoS One. 2025;20:e0336693.
PubMed
Abstract available

Thank you for your interest in scientific medicine.

AMEDEO Cervical Cancer is free of charge.

;